We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-1.75%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$742M
AUM Growth
+$71.9M
Cap. Flow
+$95.5M
Cap. Flow %
12.87%
Top 10 Hldgs %
60.42%
Holding
166
New
21
Increased
99
Reduced
7
Closed
7

Top Buys

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$23M
2
ETP
Energy Transfer Partners, L.P.
ETP
+$18.5M
3
WPZ
Williams Partners L.P.
WPZ
+$12.3M
4
BPL
Buckeye Partners, L.P.
BPL
+$9.48M
5
EPD icon
Enterprise Products Partners
EPD
+$8.44M

Top Sells

Rank Stock Value
1
OKS
Oneok Partners LP
OKS
+$34.2M
2
PAA icon
Plains All American Pipeline
PAA
+$1.69M
3
CEQP
Crestwood Equity Partners LP
CEQP
+$1.62M
4
MMP
Magellan Midstream Partners, L.P.
MMP
+$1.55M
5
FNCL icon
Fidelity MSCI Financials Index ETF
FNCL
+$1.4M

Sector Composition

Rank Sector Weight
1 Energy 73.54%
2 Healthcare 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NGNE icon
126
Neurogene
NGNE
$696M
$339K 0.05%
1,193
+109
+10% +$31.3K
KDNY
127
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$327K 0.04%
6,137
+561
+10% +$33.3K
RIGL icon
128
Rigel Pharmaceuticals
RIGL
$680M
$321K 0.04%
12,639
+1,156
+10% +$28.1K
JNCE
129
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$316K 0.04%
20,298
+1,856
+10% +$26.2K
TTPH
130
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$308K 0.04%
2,250
+206
+10% +$27.6K
BCRX icon
131
BioCryst Pharmaceuticals
BCRX
$2.37B
$298K 0.04%
56,873
+5,202
+10% +$26.6K
RARE icon
132
Ultragenyx Pharmaceutical
RARE
$2.65B
$285K 0.04%
5,343
+488
+10% +$28.9K
UPW icon
133
ProShares Ultra Utilities
UPW
$18.8M
$277K 0.04%
23,200
+348
+2% +$4.19K
GERN icon
134
Geron
GERN
$911M
$273K 0.04%
125,425
+11,473
+10% +$27.1K
SAGE
135
DELISTED
Sage Therapeutics
SAGE
$264K 0.04%
4,234
+388
+10% +$30.5K
INO icon
136
Inovio Pharmaceuticals
INO
$79.8M
$261K 0.04%
3,436
+314
+10% +$23.4K
NERV icon
137
Minerva Neurosciences
NERV
$188M
$260K 0.04%
4,273
+391
+10% +$22.4K
TVRD
138
Tvardi Therapeutics
TVRD
$23.5M
$259K 0.03%
525
+48
+10% +$24K
LXRX icon
139
Lexicon Pharmaceuticals
LXRX
$1.02B
$239K 0.03%
19,472
+1,781
+10% +$26.3K
USO icon
140
CALL
United States Oil Fund
USO
$2.45B
$175K 0.02%
+10,902
New +$859K
SPY icon
141
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$111K 0.02%
+1,800
New +$444K
DM
142
DELISTED
Dominion Energy Midstream Ptr LP
DM
$102K 0.01%
+3,189
New +$90.6K
SIOX
143
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$97K 0.01%
1,769
+162
+10% +$27.3K
UNG icon
144
CALL
United States Natural Gas Fund
UNG
$470M
$82K 0.01%
+2,563
New +$270K
ARAV
145
DELISTED
Aravive, Inc. Common Stock
ARAV
$49K 0.01%
3,332
+305
+10% +$30.8K
JPM icon
146
CALL
JPMorgan Chase
JPM
$939B
$45K 0.01%
+9,000
New +$830K
ET icon
147
PUT
Energy Transfer Partners
ET
$70.1B
$32K ﹤0.01%
+7,942
New +$139K
OEF icon
148
CALL
iShares S&P 100 ETF
OEF
$19.8B
$25K ﹤0.01%
+12,432
New +$1.36M
OKE icon
149
PUT
Oneok
OKE
$58.7B
$20K ﹤0.01%
+2,000
New +$108K
KMI icon
150
CALL
Kinder Morgan
KMI
$73.1B
$16K ﹤0.01%
+4,000
New +$77.9K
3 4 5
6
7

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q3 2017 Portfolio in Review

As of Q3 2017, Virtus ETF Advisers held 166 positions worth $742M, up 11% from $670M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Virtus ETF Advisers deployed $95.5M of net new capital in Q3 2017, opening 21 new positions and adding to 99 existing holdings. Its largest new stake was Direxion Daily Financial Bull 3x ETF: 20,503 shares worth $1.15M.

By sector, the portfolio is most concentrated in Energy at 74% of assets, down from 74% a quarter earlier, followed by Healthcare.

On the sell side, the largest reduction was Plains All American Pipeline, an estimated $1.69M trimmed.

  • Virtus ETF Advisers's largest Q3 2017 buy was Direxion Daily Financial Bull 3x ETF: 20,503 shares worth $1.15M.
  • Virtus ETF Advisers added most to Marathon Petroleum in Q3 2017, an estimated $23M increase.
  • Virtus ETF Advisers's biggest Q3 2017 reduction was Plains All American Pipeline, cutting an estimated $1.69M.
  • Virtus ETF Advisers fully exited Oneok Partners LP in Q3 2017, selling an estimated $34.2M.
  • Virtus ETF Advisers's ten largest holdings make up 60% of its $742M portfolio in Q3 2017.
  • Virtus ETF Advisers opened 21 new positions and closed 7 in Q3 2017.
  • Virtus ETF Advisers's portfolio value rose 11% quarter-over-quarter to $742M.

Based on Virtus ETF Advisers's 13F filing for Q3 2017, filed 14 Nov 2017.